<DOC>
	<DOCNO>NCT00001452</DOCNO>
	<brief_summary>Lentiginosis refers group disease mark presence pigment spots skin . These condition commonly associate multiple tumor change hormone produce gland . The cause diseases unknown , researcher suggest may level inheritance involve development . Meaning say disease may `` run family '' pass form generation generation . Primary pigment nodular adrenocortical disease ( PPNAD ) pituitary-independent , primary adrenal form hypercortisolism characterize ; 1 . &lt; TAB &gt; Resistance suppression drug dexamethasone 2 . &lt; TAB &gt; The body unable secrete cortisol normal rhythm 3 . &lt; TAB &gt; Distinct microscopic change adrenal gland PPNAD associate tumor ( myxoma ) skin , heart , breast , tumor ( swannomas ) nerve sheath , pigment spot ( nevi lentigo ) skin , growth hormone ( GH ) produce tumor pituitary gland , tumor testicle , ovary , thyroid gland . In presence association condition refer Carney Complex . Presently test screen PPNAD Carney Complex . In addition , unknown condition genetically transfer generation generation . This study propose use standard method clinical test endocrine nonendocrine diseases genetic test order ; 1 . &lt; TAB &gt; Define genetic basis PPNAD and/or Carney Complex . 2 . &lt; TAB &gt; Determine molecular change associate development tumor . 3 . &lt; TAB &gt; Identify carrier disease . 4 . &lt; TAB &gt; Determine prognosis carrier affect individual . 5 . &lt; TAB &gt; Provide sufficient data genetic counseling family PPNAD and/or Carney Complex. &lt; TAB &gt;</brief_summary>
	<brief_title>Defining Genetic Basis Development Primary Pigmented Nodular Adrenocortical Disease ( PPNAD ) Carney Complex</brief_title>
	<detailed_description>Primary pigment nodular adrenocortical disease ( PPNAD ) pituitary-independent , primary adrenal form hypercortisolism characterize ( ) resistance suppression dexamethasone abolition normal diurnal rhythm cortisol secretion , ( b ) distinctive , bilateral , histopathologic change adrenal gland , formation variably size , pigment nodular adenoma , loss normal zonation atrophy extranodular cortex . PPNAD associate variety manifestation , myxoma skin , heart , breast site , psammomatous melanotic swannomas involve peripheral nervous system ( PNS ) , lentigines blue nevi skin mucosa , growth hormone ( GH ) -producing adenomas pituitary , testicular Sertoli cell tumor , possibly neoplasm ( adrenocortical thyroid follicular carcinoma , ovarian cyst ) . These association constitute distinct clinical syndrome , Carney complex , genetic syndrome . At present , standardized screening test member family affected individual molecular mechanism ( ) hereditary single and/or multiple neoplasia syndrome completely elucidate ( e.g . patient meet clinical criterion Carney complex test negative PRKAR1A mutation . This study seek define genetic basis PPNAD and/or Carney complex sporadic familial case molecular pathogenesis tumor , identify carrier familial form disease , determine prognosis carrier affect individual . The method include standard clinical test endocrine nonendocrine pathologic condition subject study , linkage analysis DNA marker area genome likely harbor responsible gene ( ) , finally genetic screening gene . Molecular study tumor patient provide additional clue pathophysiologic mechanism lead PPNAD/Carney complex . The study ultimately provide sufficient data genetic counseling family PPNAD and/or Carney complex , , ultimately , mean genetic screen prenatal testing .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Lentigo</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Carney Complex</mesh_term>
	<mesh_term>Neoplastic Syndromes , Hereditary</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . All patient PPNAD and/or Carney Complex history sibling , child parent . Additional relatives family suspect disorder clinical ground recruit : 1 . PPNAD patient include diagnosis fully document . Firstdegree relatives patient disease accept also evaluation , already conclusively evaluate elsewhere , DNA linkage analysis . 2 . Patients suspect Carney complex accept evaluation and/or DNA analysis linkage , least two follow : 1. cardiac myxoma 2. cutaneous myxoma 3. breast myxoma 4. oral myxoma 5. myxoma external ear 6. spotty mucocutaneous pigmentation ( lentigo ) 7. testicular tumor 8. pituitary growth hormone secrete adenoma 9. nerve tumor , psammomatous melanotic schwannoma 10. first , second , thirddegree relative Carney complex ( c ) Patients one familial lentiginosis syndrome : PeutzJeghers LEOPARD syndrome , form familial lentiginosis . EXCLUSION CRITERIA : 1 . For DNA analysis linkage study : 1 . Unwillingness participate . 2 . For clinical evaluation DNA analysis/linkage study : 1 . Patients major illness , severe renal failure , restrictive obstructive lung disease , cardiac disease , anemia and/or terminal cancer able undergo appropriate test stress hospitalization . Also , patient Carney complex know heart tumor ( heart myxoma ) able enter clinical part study surgical treatment tumor . These patient , however , ask participate DNA analysis study .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2, 2017</verification_date>
	<keyword>Cushing Syndrome</keyword>
	<keyword>Gene Mapping</keyword>
	<keyword>Linkage</keyword>
	<keyword>Oncogene</keyword>
	<keyword>Linkage Analysis</keyword>
	<keyword>Gene Identification</keyword>
	<keyword>Tumors</keyword>
	<keyword>Familial Neoplasia</keyword>
	<keyword>Adrenal Gland</keyword>
	<keyword>Lentigines</keyword>
	<keyword>Carney Complex</keyword>
</DOC>